Revolune and MindPeak Unveil Innovative Multiplex Immunofluorescence Workflow at AACR 2026
At the upcoming American Association for Cancer Research (AACR) Annual Meeting in 2026, Revolune GmbH and MindPeak will present their collaborative innovation in multiplex immunofluorescence (mIF) workflows. Together, these two pioneering companies aim to streamline spatial biology processes, enabling researchers to expand their understanding of complex tissue systems.
Revolune focuses on enhancing spatial biology by providing robust mIF reagents that simplify experimental workflows. The company’s dedication to ease of use promises to empower researchers with the tools necessary for revealing significant biological insights. By integrating MindPeak’s AI-powered image analysis solutions, they are set to transform how researchers analyze and interpret multiplex tissue data.
Multiplex immunofluorescence is increasingly recognized as a crucial method for exploring tumor biology, immune interactions, and the spatial context of biomarkers. Despite this potential, existing multiplex workflows can be technologically daunting and challenging to implement on a larger scale. The collaboration between Revolune and MindPeak intends to address these barriers, presenting an accessible and cohesive approach in which staining and analysis are seamlessly combined.
Florian Leiss, CEO of Revolune, emphasizes the necessity of hybrid experimental workflows and reliable data interpretation in spatial biology. "By merging our mIF chemistry with MindPeak's sophisticated AI-driven analysis, we strive to streamline the journey from raw tissue samples to pivotal spatial insights." This alignment promises researchers an opportunity to focus on their investigations rather than the complexities of their tools.
MindPeak, renowned for its innovations in AI-powered pathology, allows automated analysis of multiplex imaging data. This means researchers can not only conduct qualitative assessments of biomarkers but also make sense of spatial interpretations across intricate tissue samples.
Felix Faber, CEO of MindPeak, shares his enthusiasm for this partnership. "We are thrilled to collaborate with Revolune in supporting researchers who work with multiplex tissue data. Our shared goal is to minimize the hurdles that often hinder the adoption of spatial biology workflows, making research more efficient and effective."
At AACR 2026, attendees will have the opportunity to discover more about this integrated approach by visiting the joint exhibit at booth 1660. Both companies will discuss how their innovative staining and analysis solutions can advance cancer research and accelerate biomarker discovery.
Founded to simplify spatial biology, Revolune develops advanced multiplex immunofluorescence solutions that are as accessible as immunohistochemistry (IHC). By creating reagents that prioritize clarity and speed, Revolune endeavors to assist researchers in comprehending complex tissue systems. The company’s emphasis on reliable workflows is crucial for nurturing translational and biopharmaceutical research. Visit revolune.de for more details.
Founded in 2018, MindPeak is a leader in the field of AI-driven digital pathology, serving as a bridge between biomarker discovery and clinical diagnostics. The technology they offer enables laboratories to derive actionable insights from tissue images, promoting both routine diagnostics and the translation of new biomarkers for practical clinical use. For additional information, visit mindpeak.ai or follow them on LinkedIn.
Revolune focuses on enhancing spatial biology by providing robust mIF reagents that simplify experimental workflows. The company’s dedication to ease of use promises to empower researchers with the tools necessary for revealing significant biological insights. By integrating MindPeak’s AI-powered image analysis solutions, they are set to transform how researchers analyze and interpret multiplex tissue data.
Multiplex immunofluorescence is increasingly recognized as a crucial method for exploring tumor biology, immune interactions, and the spatial context of biomarkers. Despite this potential, existing multiplex workflows can be technologically daunting and challenging to implement on a larger scale. The collaboration between Revolune and MindPeak intends to address these barriers, presenting an accessible and cohesive approach in which staining and analysis are seamlessly combined.
Florian Leiss, CEO of Revolune, emphasizes the necessity of hybrid experimental workflows and reliable data interpretation in spatial biology. "By merging our mIF chemistry with MindPeak's sophisticated AI-driven analysis, we strive to streamline the journey from raw tissue samples to pivotal spatial insights." This alignment promises researchers an opportunity to focus on their investigations rather than the complexities of their tools.
MindPeak, renowned for its innovations in AI-powered pathology, allows automated analysis of multiplex imaging data. This means researchers can not only conduct qualitative assessments of biomarkers but also make sense of spatial interpretations across intricate tissue samples.
Felix Faber, CEO of MindPeak, shares his enthusiasm for this partnership. "We are thrilled to collaborate with Revolune in supporting researchers who work with multiplex tissue data. Our shared goal is to minimize the hurdles that often hinder the adoption of spatial biology workflows, making research more efficient and effective."
At AACR 2026, attendees will have the opportunity to discover more about this integrated approach by visiting the joint exhibit at booth 1660. Both companies will discuss how their innovative staining and analysis solutions can advance cancer research and accelerate biomarker discovery.
About Revolune
Founded to simplify spatial biology, Revolune develops advanced multiplex immunofluorescence solutions that are as accessible as immunohistochemistry (IHC). By creating reagents that prioritize clarity and speed, Revolune endeavors to assist researchers in comprehending complex tissue systems. The company’s emphasis on reliable workflows is crucial for nurturing translational and biopharmaceutical research. Visit revolune.de for more details.
About MindPeak
Founded in 2018, MindPeak is a leader in the field of AI-driven digital pathology, serving as a bridge between biomarker discovery and clinical diagnostics. The technology they offer enables laboratories to derive actionable insights from tissue images, promoting both routine diagnostics and the translation of new biomarkers for practical clinical use. For additional information, visit mindpeak.ai or follow them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.